ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

DCCP Payback System Saving $1 Million Year

December 3, 1982

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

NIH Workshop On Animal Care Planned

May 4, 1990